ArticleCancer cell international2025

GPR34 inhibition reprograms tumor-associated macrophages and enhances the sensitivity of anti-PD-1 therapy in hepatocellular carcinoma.

Wenfeng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.